Chikungunya vaccination

The vaccine against chikungunya Ixchiq® is a live attenuated vaccine and therefore should not be used in cases of impaired immunity, during pregnancy or breastfeeding.

For whom is vaccination recommended?

• Travellers over 12 years old and under 65 years old travelling to an area with an active outbreak.
• Active outbreaks are listed in the country sheets.

Who should not get the vaccine?

• Persons with impaired immunity.
• Persons who are pregnant or breastfeeding.
• Persons under 12 years of age or over 65 years of age.

Vaccination schedule

• The schedule consists of 1 dose preferably more than 14 days before departure.
• The duration of protection has not yet been determined.

Side effects

• Muscle pain, joint pain, headache, fever and local skin reactions are frequently (>10%) reported after vaccination.
• There have been reports of serious adverse events in people over 65 years of age with underlying conditions. These reports are currently under investigation. As a precaution, the vaccine will not be administered to persons aged 65 and over for the time being, pending the investigation results.

Additional information for doctors

• Information on chikungunya vaccination for doctors